Dr Reddys Laboratories (RDY) Return on Assets [ROA] (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Return on Assets [ROA] of 4.97% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 6.16 percentage points from 11.12% a year earlier and down 1.05 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories posted Return on Assets [ROA] of 7.57%, down 5.31 percentage points from FY2025.
- Return on Assets [ROA] has a five-year change of +0.53 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Assets [ROA] came in at 12.88% in FY2025 (-2.72 pp), 15.60% in FY2024 (+1.50 pp), 14.09% in FY2023 (+5.79 pp) and 8.30% in FY2022 (+1.27 pp).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Return on Assets [ROA] since fiscal Q4 2011.
- Year over year, Return on Assets [ROA] has now declined in each of the last 11 quarters, with an average year-over-year change of -3.46 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was fiscal Q1 2024 (a gain of 7.84 percentage points); the low point was fiscal Q2 2027 (a drop of 6.16 percentage points).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at 6.02% (Q1 2027), 7.83% (Q4 2026) and 10.42% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.00% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 4.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.97% |
| Jun 30, 2026 | 6.02% |
| Mar 31, 2026 | 7.83% |
| Dec 31, 2025 | 10.42% |
| Sep 30, 2025 | 11.12% |
| Jun 30, 2025 | 11.39% |
| Mar 31, 2025 | 11.90% |
| Dec 31, 2024 | 11.65% |
| Sep 30, 2024 | 12.33% |
| Jun 30, 2024 | 13.90% |
| Mar 31, 2024 | 14.82% |
| Dec 31, 2023 | 15.90% |
| Sep 30, 2023 | 15.58% |
| Jun 30, 2023 | 15.40% |
| Mar 31, 2023 | 14.97% |
| Dec 31, 2022 | 11.38% |
| Sep 30, 2022 | 9.47% |
| Jun 30, 2022 | 7.56% |
| Mar 31, 2022 | 7.49% |
| Dec 31, 2021 | 9.33% |
API Access
Dr Reddys Laboratories Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();